Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population (GWprofamilia)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00847340 |
Recruitment Status
:
Completed
First Posted
: February 19, 2009
Last Update Posted
: March 20, 2012
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
HPV infection has been recognized as the most prevalent sexual transmitted infection worldwide. Burden of many HPV related diseases is well known particularly regarding the different associated cancers (cervical, anal, vaginal, vulvar, oro-pharyngeal) (3) ; however, there is much less available information on the general burden of genital warts, the associated HPV types, the costs of related medical treatments and the knowledge and perceptions towards the disease and its prevention.
Objectives:
- To determine the HPV genotypes distribution in genital warts in the study population.
- To assess the knowledge about transmission & prevention of HPV infection related diseases
- To determine the direct medical costs of genital warts attention.
Condition or disease | Intervention/treatment |
---|---|
Genital Warts HPV Infections | Procedure: Biopsy Excisional |
Study population
Female and male between 18 - 45 years of age living in Bogota, Colombia
Sample frame
Patients attending to gynecologic or STD consult in a mayor out patient clinic in Bogotá (PROFAMILIA)
Analysis
Analysis of the information will be exhaustive. We will calculate prevalence of HPV genotypes in the GW in both sexes separately. Analyses of the survey will include simple frequencies, percentages, and comparison of results related to HPV knowledge with sociodemographic and clinical information. Explorative analysis using parametric or non parametric statistics of the items included in the questionnaire and clinical forms will be done as appropriate. We will calculate the medical cost of patients enrolled in the study. The treatment protocols used for this protocol will reflect the current clinical practice accepted for the treatment of genital warts. We will use national reference cost list (SOAT) to determine the cost of procedures included.
Study Type : | Observational |
Actual Enrollment : | 342 participants |
Observational Model: | Case-Only |
Time Perspective: | Cross-Sectional |
Official Title: | Prevalence of HPV Genotypes in Genital Warts in Colombian Male and Female Population Attending Medical Services. |
Study Start Date : | December 2009 |
Actual Primary Completion Date : | September 2010 |
Actual Study Completion Date : | September 2010 |

-
Procedure: Biopsy Excisional

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients attending to gynecologic or STD consult in a mayor out patient clinic in Bogotá (PROFAMILIA).
Female and male between 18 - 45 years of age living in Bogota, Colombia.
Inclusion Criteria:
- Age between 18-45 years.
- Lesions suspicious of being HPV related.
-
The main manifestations of anogenital warts include:
- Cauliflower-like condylomata acuminata lesions that usually involve moist surfaces
- keratotic and smooth papular warts, usually on dry surfaces
- subclinical "flat" warts, that can be found on any mucosal or cutaneous surface and, which are probably overseen in the majority of cases.
- Lesions other than the described above, are not to be biopsied, according to the investigator criteria.
Exclusion Criteria:
- Not willing to participate
- To be a participant in any HPV vaccine clinical trial study
- Known immune suppressive disease.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00847340
Principal Investigator: | Gustavo J. Hernandez-Suarez, MD | Research & Development Fundation (FID) |
Responsible Party: | Gustavo Hernandez-Suarez, MD MSc, La Fundacion para la Investigacion y el Desarrollo |
ClinicalTrials.gov Identifier: | NCT00847340 History of Changes |
Other Study ID Numbers: |
protocol V profamilia |
First Posted: | February 19, 2009 Key Record Dates |
Last Update Posted: | March 20, 2012 |
Last Verified: | March 2012 |
Keywords provided by Gustavo Hernandez-Suarez, La Fundacion para la Investigacion y el Desarrollo:
Genital warts HPV typing HPV infections Condyloma Acuminata |
Additional relevant MeSH terms:
Warts Condylomata Acuminata Papillomavirus Infections DNA Virus Infections Virus Diseases Skin Diseases, Viral |
Tumor Virus Infections Skin Diseases, Infectious Skin Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases |